New Drug Review

Meropenem/Vaborbactam for Complicated UTIsVabomere combines a carbapenem and a beta-lactamase inhibitor as a treatment for complicated urinary tract infections.
FDA Approves Emicizumab-kxwh for Hemophilia A
FDA Approves Emicizumab-kxwh for Hemophilia AEmicizumab-kxwh brings together factors IXa and X to restore the function of the missing activated factor VIII and the blood clotting process.
Tisagenlecleucel (Kymriah) for Acute Lymphoblastic Leukemia
Tisagenlecleucel (Kymriah) for Acute Lymphoblastic LeukemiaA new era of treatment has arrived—here’s what you need to know.